Network pharmacological and bioinformatic analyses predicted that ECH induces ferroptosis in HCC by modulating the TP53/SLC7A11/GPX4 pathway (upregulating TP53 and downregulating SLC7A11/GPX4). Here, TP53 is linked to hepatocellular carcinoma.